RGC

Regencell Bioscience Holdings Limited

HealthcareDrug Manufacturers - Specialty & GenericHKUSDPeers →Country macro →

$12.01

LiveJun 18, 2026

Market cap

$5.94B

52w range

9.39 – 69.00

P / E

—

EPS

—

Volume

380.69K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Regencell Bioscience Holdings Limited’s valuation

No corporate actions

No dividend or split records loaded for RGC-US.